Los Angeles Capital Management’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$272K Sell
117,740
-25,070
-18% -$57.9K ﹤0.01% 1088
2025
Q1
$199K Buy
142,810
+5,350
+4% +$7.44K ﹤0.01% 1013
2024
Q4
$238K Sell
137,460
-69,532
-34% -$120K ﹤0.01% 1008
2024
Q3
$416K Buy
+206,992
New +$416K ﹤0.01% 914